The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
So I think we can expect results in the next two weeks.
Nobles were delayed by the lab being closed for 2 weeks over Christmas.
But despite all that you still invested? Wow.
Must he institutions...TR-1 time hopefully tomorrow.
If the independent lab verification is just a rubber stamp, could discussions not already be taking place?
Nobles test results were delayed by 2 weeks over Christmas due to the lab being shut!
I can't help but think would you raise 4.7m from long term supportive investors if you were going to announce any dudd news soon? I don't think so.....
Thanks Blubay....how long does all that take and forgive my ignorance but why will the lab results take 6-8 weeks to come through???
What a shame a significant improvement in the share price wasn't one of the objectives.
To calm nerves on CYP2C19, would be good to hear how the Manchester devote project is going.
Not great news indeed but I suspect its a problem with the consultation process rather than the test itself. SP will be under pressure tomorrow unless we have some good news.
Let's see Crooty come Friday night who is right!
A joint venture for instance with the partner funding the application process with in return a share in future profits.
There are other funding options not involving a share dilution re FDA...
I think we will definitely have some news this week...FDA, specialist commissioning update, further take up, NICE update etc etc. Take your pick!
Let's very much hope they have sold a lot and we will hear soon. Toby Foster is a big catch to have selling so let's hope he has justified his fee!
Roger, you were telling us last week you had bought more shares....now a few days later its all doom and gloom. Seems a rather odd way of investing!
The company had no direction under David Budd, we now have someone who understands what it takes to commercialise world leading products.
All very quiet at the moment - I assume loads is being achieved in the background, which we should hopefully hear back on soon. I am genuinely surprised we have not heard on the FDA route / partners, perhaps there is a bit more to it then James alluded to in the November presentation??
Excellent summary Eureka01 - as you say lots of positive updates imminent. Timescales are always notoriously difficult to predict in the medical world especially when you are relying on regulators etc. I would also be keen to hear how the Manchester roll out of CYP2C19 and also whether there has been any international interest (research only) for it. Specialist commissioning for MT-RNR1 should be soon too, which is a big game changer. Hold firm!